For: | Hou Q, Duan ZJ. Metabonomic window into hepatitis B virus-related hepatic diseases. World J Hepatol 2016; 8(1): 1-8 [PMID: 26783418 DOI: 10.4254/wjh.v8.i1.1] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v8/i1/1.htm |
Number | Citing Articles |
1 |
Jiahui Chen, Liqiong Chen, Bin Li, Qi Zhao, Yan Cheng, Dongmei Yan, Hongning Liu, Fei Li. Mass spectrometry‐based metabolomics reveals metabolism of molnupiravir may lead to metabolic disorders and hepatotoxicity. Biomedical Chromatography 2024; 38(11) doi: 10.1002/bmc.5996
|
2 |
Hongxia Fan, Qiaoge Zhang, Xiaopei Zhao, Ping Lv, Min Liu, Hua Tang. Transcriptomic profiling of long non-coding RNAs in hepatitis B virus-related hepatocellular carcinoma. Oncotarget 2017; 8(39): 65421 doi: 10.18632/oncotarget.18897
|
3 |
Metabolome alterations in Clonorchis sinensis after treatment with tribendimidine and praziquante in vivo. Acta Tropica 2022; 230: 106330 doi: 10.1016/j.actatropica.2022.106330
|
4 |
Diren Beyoğlu, Jeffrey R. Idle. Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy. Metabolites 2020; 10(2): 50 doi: 10.3390/metabo10020050
|
5 |
Yidan Sun, Shuhan Tang, Yaqi Xu, Hao Li, Pengyu Li, Masao Hattori, Hailong Zhang, Xianna Li, Zhigang Wang. Anti-HBV activity of (R)-gentiandiol, a metabolite of Swertiamarin, in transgenic mice: Insights from non-targeted serum metabolomics. Bioorganic & Medicinal Chemistry 2025; 121: 118128 doi: 10.1016/j.bmc.2025.118128
|